TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis

(TIDE Trial)

Recruiting in Palo Alto (17 mi)

+6 other locations

Overseen by Sven Vanneste, Prof.

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Regensburg

No Placebo Group

Trial Summary

What is the purpose of this trial?

Research in clinical neuroscience is founded on the conviction that a better understanding of tinnitus related changes of brain function will improve our ability to diagnose and treat tinnitus. Although considerable advances have been made in understanding the mechanisms of tinnitus, the clinical management of tinnitus remains largely based on a 'trial and error' approach. The identification and validation of a biomarker for tinnitus is thought to be the crucial step in the development of a personalized approach to the diagnosis and treatment of tinnitus. The overarching goal of this study is to incorporate advanced technologies to provide an objective, data-driven, personalized approach to the diagnosis of chronic tinnitus. This should lead to a clinically applicable tool that can be widely and easily used.

Research Team

Sven Vanneste, Prof.

Principal Investigator

Trinnitus College Dublin

Eligibility Criteria

Inclusion Criteria

I have had constant tinnitus for at least 6 months.

I have never experienced ringing in my ears.

I am between 18 and 70 years old.

Treatment Details

Participant Groups

Group I: Tinnitus cases/patients Experimental Treatment 1 Intervention

Subjects that have a diagnosis of chronic and constant tinnitus (for at least 6 months based on history)

Group II: Control group Experimental Treatment 1 Intervention

Subjects that never experienced tinnitus (excluding short-term tinnitus, i.e. not tinnitus that persists over a longer period of time)

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

University of Illinois Champaign, IL

University of Texas Austin, TX

Who Is Running the Clinical Trial?

University of Regensburg

Lead Sponsor

Trials

93

Patients Recruited

36,400+

University of Dublin, Trinity College

Collaborator

Trials

117

Patients Recruited

36,200+

Brai3n - Brain Research Center for Advanced, Innovative, Interdisciplinary and International Neuromodulation

Collaborator

Trials

1

Patients Recruited

560+

University of Texas at Austin

Collaborator

Trials

387

Patients Recruited

86,100+

Eastern Switzerland University of Applied Sciences

Collaborator

Trials

6

Patients Recruited

730+

Universität Tübingen

Collaborator

Trials

30

Patients Recruited

14,900+

University Hospital, Zürich

Collaborator

Trials

89

Patients Recruited

628,000+

University of Illinois at Urbana-Champaign

Collaborator

Trials

203

Patients Recruited

40,600+